Also trades as: GLTO (NASDAQ) · $vol 6M
DMRA NASDAQ
Damora Therapeutics, Inc.
1W: -10.8%
1M: +30.4%
3M: +18.9%
YTD: +23.1%
$29.42
-0.02 (-0.07%)
Weekly Expected Move ±14.8%
$20
$25
$29
$33
$37
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.8B
52W Range2.45-38.325
Volume305,472
Avg Volume571,836
Beta1.47
Dividend—
Analyst Ratings
Company Info
CEOJennifer A. Jarrett
Employees7
SectorHealthcare
IndustryBiotechnology
IPO Date2020-10-29
Websitedamoratx.com
75 State Street
Waltham, MA 02453
US
Waltham, MA 02453
US
457 070 5210
About Damora Therapeutics, Inc.
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Latest News
Is Broad Russell Index Inclusion Altering The Investment Case For Damora Therapeutics (DMRA)? - simplywall.st
Damora Therapeutics general counsel sells $7,345 in stock By Investing.com - Investing.com Nigeria
Damora Therapeutics general counsel sells $7,345 in stock - Investing.com
[Form 4] Damora Therapeutics, Inc. Insider Trading Activity - Stock Titan
Damora Therapeutics (DMRA) Joins Russell Indexes With Valuation Still Looking About Right - simplywall.st
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Winslow Garrett | S-Sale | 245 | $29.98 | 2026-07-06 |
| Winslow Garrett | M-Exempt | 680 | — | 2026-07-03 |
| Winslow Garrett | M-Exempt | 680 | — | 2026-07-03 |
| Burkavage Brian | 312,535 | $32.00 | 2026-05-01 | |
| Jarrett Jennifer | A-Award | 1,500,000 | $25.50 | 2026-03-30 |